The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients


OZCELIK M., ODABAS H., ERCELEP O., YUKSEL S., MERT A. G. , AYDIN D., ...More

CLINICAL & TRANSLATIONAL ONCOLOGY, vol.18, no.6, pp.617-624, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 6
  • Publication Date: 2016
  • Doi Number: 10.1007/s12094-015-1408-6
  • Title of Journal : CLINICAL & TRANSLATIONAL ONCOLOGY
  • Page Numbers: pp.617-624

Abstract

The optimal treatment in older persons with metastatic colorectal cancer (mCRC) is complicated by a lack of general agreement. The aim of this study was to evaluate the activity of bevacizumab plus capecitabine combination in elderly mCRC patients who were not suitable for chemotherapy with irinotecan and oxaliplatin-containing regimens.